WASHINGTON (AP) — A House lawmaker says former Turing Pharmaceuticals CEO Martin Shkreli, reviled for price hiking, has not made legal arrangements to appear before Congress next week, despite receiving a subpoena. House lawmakers want to question Shkreli about his decision to hike the price of Daraprim, the only approved drug for a rare and sometimes deadly parasitic infection, by 5,000 percent.

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News